Lentiviral Vector Production (18 and 21 types) Complete Set
Open tenderJapanese title: レンチウイルスベクター作製 (18種・21種) 一式
Overview
The National Cancer Center is procuring a complete set of lentiviral vector production services for 18 and 21 types. The contract period is from the contract signing date until November 30, 2026, with delivery and performance at the National Cancer Center and contracted sites. The procurement includes all related expenses such as equipment, materials, and transportation.
Key Details
- Source: KKJ
- Notice type: Open tender
- Listed on KKJ: September 11, 2026
- Procuring entity: Manno Hiroyuki, Director of the National Cancer Center
- Deadline to obtain tender documents: October 7, 2026 (passed)
- Submission deadline: October 7, 2026, 17:00 JST
- Award method: Lowest-price award
- Eligibility (from notice): All-ministry unified qualification, 'services', grade A–D, Kanto-Koshinetsu region – verify in the tender documents
- Status: Expired
- Technology relevance: Possible
- Business-action likelihood: Medium – Open competitive bidding with detailed qualification requirements and a defined deadline, but participation may require local compliance and partnership.
Official Notice
Official Source
KKJ, Japan's Government Procurement Information Website, which aggregates procurement notices from national and local public-sector organizations.
- Source: KKJ (Government Procurement Information Website)
- Official category: Open competitive tender
- Listed on KKJ: September 11, 2026
- Publication: Official notice document (PDF)
Full English Translation
The following English translation was prepared from the original Japanese notice published by the procuring entity and listed on KKJ, Japan's Government Procurement Information Website. The translation below is based on the Japanese source text.
September 11, 2026
The following is subject to open competitive bidding.
National Research and Development Agency
National Cancer Center
Director Manno Hiroyuki
1. Items subject to competitive bidding
(1) Procurement subject and quantity
Lentiviral vector production (18 types and 21 types) complete set
(2) Characteristics of the procurement subject
According to the bidding documents and specifications
(3) Delivery deadline or performance period
From contract signing date until November 30, 2026
(4) Delivery or performance location
National Cancer Center and contracted performance sites
(5) Bidding method
The first negotiation right holder will be determined by the lowest price bidding method,
① The bid submitted by bidders shall include direct expenses related to the procurement subject, as well as all expenses required for the outsourcing work such as equipment, materials, machinery, transportation, etc., and estimate the contract amount.
② In determining the first negotiation right holder, the bid amount plus 10% of that amount (if there is a fraction less than 1 yen, it will be rounded down) will be considered the winning bid amount. Bidders must submit a bid stating the amount equivalent to 100/110 of the estimated contract amount regardless of whether they are taxable or tax-exempt businesses.
*Excluding non-taxable transactions
2. Qualifications required for participants in the competition
(1) Those who fall under the provisions of Articles 6 and 7 of the National Cancer Center Contract Handling Rules cannot participate.
(2) Those who fall under the following may be excluded from participation:
① Those who have false statements in qualification application or attached documents
② Those whose management condition or creditworthiness has severely deteriorated
(3) Those rated A, B, C, or D in the "Provision of Services, etc." category in the unified qualification notification and have competition qualifications in the Kanto-Koshinetsu region.
(4) Those who can prove a system for prompt after-sales service and maintenance related to purchased goods, except for service provision.
3. Place and period for showing contract terms
Place for contract terms, delivery of bidding documents, and submission of bids:
Procurement Section 2, Finance and Accounting Department, National Cancer Center
5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045
Period for delivery of bidding documents:
September 11 to October 7, 2026 (Weekdays 8:30-17:00, last day until noon)
Bid receipt deadline:
October 7, 2026, 17:00 (must arrive by then)
4. Place and date of competition execution
Place: National Cancer Center, Administration Building 1F, Meeting Room 4, 5-1-1 Tsukiji, Chuo-ku, Tokyo
Date: October 9, 2026, 13:45
5. Other matters
(1) Language and currency for contract procedures
Japanese and Japanese currency
(2) Invalid bids
Bids submitted by those without qualification or who fail to fulfill obligations will be invalid.
(3) Necessity of contract document
Required
(4) Method of contractor decision
Among bidders who submit bids with documents/materials according to this announcement and bidding documents, meet all qualification and specification requirements, and whose bid is within the estimated price limit under Article 37 of the Contract Handling Rules, the lowest price bidder will be the first negotiation right holder and the negotiation partner.
(5) Others
Details are according to the bidding documents.
[Contact]
Procurement Section 2, Finance and Accounting Department, National Cancer Center
Phone: 03-3542-2511 (ext. 2163)
Show original Japanese notice
入 札 公 告
令 和8年9月1 1日次のとおり一般競争に付す。国立研究開発法人国立がん研究センター理事長 間野 博行1 競争入札に付する事項(1)調達件名及び数量レンチウイルスベクター作製 (18種・21種) 一式(2)調達件名の特質等入札説明書及び仕様書による(3)納入等期限又は履行期間契約締結日から令和8年11月30日まで(4)納入場所又は履行場所国立がん研究センター及び履行契約先(5)入札方法第一交渉権者の決定は、最低価格落札方式をもって行うので、①入札者が提出する入札書は、調達件名にかかる直接経費の他、機材、資材、機械器具、運搬費等、業務委託に要する一切の諸経費を含め、契約金額を見積もるものとする。②第一交渉権者決定にあたっては、入札書に記載された金額に当該金額の10%に相当する額を加算した金額(当該金額に1円未満の端数がある場合は、その端数金額を切り捨てた金額とする。)をもって落札金額とするので、入札者は、消費税及び地方消費税に係る課税事業者であるか免税事業者であるかを問わず、見積もった契約金額の110分の100に相当する金額を記載した入札書を提出しなければならない。※課税対象外取引を除く2 競争に参加する者に必要な資格に関する事項(1)国立研究開発法人国立がん研究センター契約事務取扱細則第6条及び7条に規定される各事項に該当される者は、競争に参加できない。(2)次の事項に該当する者は、競争に参加させないことがある。①資格審査申請書又は添付書類に虚偽の事実を記載した者②経営の状況又は信用度が極度に悪化している者(3)資格審査結果通知書(全省庁統一資格)において、「役務の提供等」のうちA,B,C又はDの等級に格付けされ、関東甲信越地域の競争資格を有する者。(4)購入物品等に係る迅速なアフターサービス・メンテナンス等の体制が整備されていることを証明したものであること。但し、役務の提供等については、この限りではない。3 契約条項を示す場所及び期間契約条項を示す場所、入札説明書の交付場所、入札書の提出場所は、次のとおりとする。〒104-0045 東京都中央区築地5-1-1国立がん研究センター財務経理部調達課調達第二係入札説明書等交付期間令和8年9月11日から令和8年10月7日まで(平日:午前8時30分から午後5時まで)(最終日のみ午前8時30分から正午まで)入札書受領期限令和8年10月7日 午後5時(必着)4 競争執行の場所及び日時場所:東京都中央区築地5-1-1国立がん研究センター管理棟1F 第4会議室日時:令和8年10月9日(金) 午後1時45分5 その他の事項(1)契約手続において使用する言語及び通貨日本語及び日本国通貨とする。(2)入札の無効本公告に示した競争参加資格のない者の提出した入札書、入札者に求められる義務を履行しなかった者の提出した入札書は無効とする。(3)契約書作成の要否要(4)契約者の決定方法本公告及び入札説明書に従い、書類・資料を添付した入札書を提出した入札者であって、本入札公告及び入札説明書の競争参加資格及び仕様書の要求、要件を全て満たし、当該入札者の入札書が国立がん研究センター契約事務取扱細則第37条の規定に基づいて作成された予定価格の制限の範囲内であり、かつ、最低価格をもって入札を行った者を第一交渉権者とし、契約交渉の相手方とする。(5)その他詳細は入札説明書による。【照会先】国立がん研究センター財務経理部調達課調達第二係電話03-3542-2511(内線2163)
Business Signal
Business Relevance
Do not proceed in the examined current route: an evidenced mandatory deadline or requirement blocks it. Other routes require separate verification.
- Product fit: Potential
- Current-case feasibility: Blocked in the examined route
- Evidence confidence: Low
- Supply-chain security: Unknown
Participation fit
Participation is expected to require appropriate Japanese government procurement eligibility, or cooperation with a suitable Japanese partner holding the required qualification. The eligibility requirements have not been fully reviewed and should be verified against the official tender documents.
This page is based on the official procurement notice published by the procuring entity and listed on KKJ, Japan's Government Procurement Information Website, with translation and a preliminary business assessment by I.J. Do. The official Japanese notice and tender documents are binding.
JBid is a beta technology-procurement intelligence service by I.J. Do.